COVID-19相关肺血栓栓塞:静脉血栓栓塞还是动脉血栓形成?
回顾性纳入109例因疑似肺栓塞行CT肺动脉造影的COVID-19住院患者,41例(40.6%)检出肺血栓栓塞,主要累及段及亚段动脉、以下叶分支为主,供血区多表现为实变。有肺栓塞组CT病变评分、D-二聚体、乳酸脱氢酶及C反应蛋白与无肺栓塞组差异有统计学意义,深静脉血栓仅见于5/41例(12.2%)。
要点
- COVID-19患者肺血栓栓塞主要累及段及亚段动脉,多位于实变区供血动脉。
- 有肺栓塞患者CT病变评分更高,D-二聚体、乳酸脱氢酶、C反应蛋白差异有统计学意义。
- 深静脉血栓仅见于12.2%的肺栓塞患者,作者据此提出可能为肺动脉原位血栓形成而非血栓栓塞。
诊断标准与关键数值
- 肺血栓栓塞检出率:41/101例(40.6%)。
- 深静脉血栓仅见于5/41例(12.2%)肺血栓栓塞患者。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To investigate CT pulmonary angiography findings of pulmonary thromboembolism (PTE) in coronavirus disease 2019 (COVID-19) and its association with clinical and radiologic conditions.
MATERIALS AND METHODS: This retrospective study includes 109 hospitalized patients with COVID-19 who underwent CT pulmonary angiography for suspected PTE from March 20 to May 3, 2020. Data were collected from our PACS. CT pulmonary angiography findings of PTE were evaluated. On the basis of the presence or absence of PTE, patients were divided into two groups, and their clinical and radiologic conditions were compared using the Mann-Whitney U test and χ2 test.
RESULTS: The study population comprised 82 men and 19 women, with a mean age of 64.1 years ± 15.0 (95% confidence interval [CI]: 60.4, 67.6) years. CT pulmonary angiography was performed 19.8 days ± 6.1 (95% CI: 18.1, 20.2) after symptom onset and 10.5 days ± 3.8 (95% CI: 10.2, 12.9) after admission. Of 101 patients, 41 had PTE (40.6%). PTE was mostly bilateral or only right (37/41 [90.2%]), mainly involved segmental (37/41 [90.2%]) or subsegmental (25/41 [61.0%]) arteries and affected mainly the branches of the lower lobe (30/41 [73.2%]). Parenchymal segments supplied by segmental arteries with PTE showed a prevalent consolidation pattern (25/37 [67.6%]). Deep vein thrombosis was present only in five of 41 (12.2%) patients. Comparing groups with and without PTE, no significant difference was observed in age, sex, symptom onset, comorbidities, tumor history, use of respiratory supports, activated partial thromboplastin time, prothrombin time, and deep vein thrombosis. Conversely, differences were evaluated in CT lesion score (15.7 ± 1.4 [95% CI: 15.3, 16.1] vs 14.1 ± 1.1 [95% CI: 13.8, 14.4]; P = .035), d-dimer level (P < .001), lactate dehydrogenase level (P < .001), and C-reactive protein level (P = .042).
CONCLUSION: PTE in COVID-19 involves mainly the segmental and subsegmental arteries of segments affected by consolidations in patients with more severe lung disease. The authors hypothesize that the development of PTE in COVID-19 might be a pulmonary artery thrombosis because of severe lung inflammation and hypercoagulability rather than thromboembolism.© RSNA, 2020.
引用
- Cavagna E, Muratore F, Ferrari F, et al. Pulmonary Thromboembolism in COVID-19: Venous Thromboembolism or Arterial Thrombosis? Radiol Cardiothorac Imaging. 2020. PMID: 33778609. doi:10.1148/ryct.2020200289
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。